{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:37:57Z","timestamp":1744155477738,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1038\/s41431-020-0633-9","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T12:06:45Z","timestamp":1589371605000},"page":"1205-1209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Predictive genetic testing in Huntington\u2019s disease: should a neurologist be involved?"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0732-4406","authenticated-orcid":false,"given":"Mayke","family":"Oosterloo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia K.","family":"Bijlsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corien C.","family":"Verschuuren-Bemelmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meyke I.","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"de Die-Smulders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymund A. C.","family":"Roos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"key":"633_CR1","doi-asserted-by":"crossref","unstructured":"The Huntington\u2019s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell . 1993;72:971\u201383.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"633_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA. Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis. 2010;5:40.","journal-title":"Orphanet J Rare Dis"},{"key":"633_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.brainresbull.2006.10.023","volume":"72","author":"A Tibben","year":"2007","unstructured":"Tibben A. Predictive testing for Huntington\u2019s disease. Brain Res Bull. 2007;72:165\u201371.","journal-title":"Brain Res Bull"},{"key":"633_CR4","doi-asserted-by":"crossref","first-page":"e00881","DOI":"10.1002\/mgg3.881","volume":"7","author":"F Ramond","year":"2019","unstructured":"Ramond F, Quadrio I, Le Vavasseur L, Chaumet H, Boyer F, Bost M, et al. Predictive testing for Huntington disease over 24 years: evolution of the profile of the participants and analysis of symptoms. Mol Genet Genom Med. 2019;7:e00881.","journal-title":"Mol Genet Genom Med"},{"key":"633_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ymgme.2010.12.001","volume":"102","author":"S Dufrasne","year":"2011","unstructured":"Dufrasne S, Roy M, Galvez M, Rosenblatt DS. Experience over fifteen years with a protocol for predictive testing for Huntington disease. Mol Genet Metab. 2011;102:494\u2013504.","journal-title":"Mol Genet Metab"},{"key":"633_CR6","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s10897-013-9678-z","volume":"23","author":"TM Scuffham","year":"2014","unstructured":"Scuffham TM, MacMillan JC. Huntington disease: who seeks presymptomatic genetic testing, why and what are the outcomes? J Genet Counseling. 2014;23:754\u201361.","journal-title":"J Genet Counseling"},{"key":"633_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/mgg3.238","volume":"5","author":"P Mandich","year":"2017","unstructured":"Mandich P, Lamp M, Gotta F, Gulli R, Iacometti A, Marchese R, et al. 1993-2014: two decades of predictive testing for Huntington\u2019s disease at the Medical Genetics Unit of the University of Genoa. Mol Genet Genom Med. 2017;5:473\u201380.","journal-title":"Mol Genet Genom Med"},{"key":"633_CR8","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s10897-018-0233-9","volume":"27","author":"MA Holman","year":"2018","unstructured":"Holman MA, Quillin J, York TP, Testa CM, Rosen AR, Norris VW. The changing age of individuals seeking presymptomatic genetic testing for huntington disease. J Genet Counseling. 2018;27:1157\u201366.","journal-title":"J Genet Counseling"},{"key":"633_CR9","doi-asserted-by":"crossref","unstructured":"International Huntington Association and the World Federation of Neurology Research Group on Huntington\u2019s Chorea. Guidelines for the molecular genetics predictive test in Huntington\u2019s disease. J Med Genet. 1994;31:555\u20139.","DOI":"10.1136\/jmg.31.7.555"},{"key":"633_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1399-0004.2012.01900.x","volume":"83","author":"R MacLeod","year":"2013","unstructured":"MacLeod R, Tibben A, Frontali M, Evers-Kiebooms G, Jones A, Martinez-Descales A, et al. Recommendations for the predictive genetic test in Huntington\u2019s disease. Clin Genet. 2013;83:221\u201331.","journal-title":"Clin Genet"},{"key":"633_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1054\/jocn.1998.0151","volume":"7","author":"E McCusker","year":"2000","unstructured":"McCusker E, Richards F, Sillence D, Wilson M, Trent RJ. Huntington\u2019s disease: neurological assessment of potential gene carriers presenting for predictive DNA testing. J Clin Neurosci: Off J Neurosurgical Soc Australas. 2000;7:38\u201341.","journal-title":"J Clin Neurosci: Off J Neurosurgical Soc Australas"},{"key":"633_CR12","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1001\/archneur.57.7.1040","volume":"57","author":"SC Kirkwood","year":"2000","unstructured":"Kirkwood SC, Siemers E, Bond C, Conneally PM, Christian JC, Foroud T. Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene. Arch Neurol. 2000;57:1040\u20134.","journal-title":"Arch Neurol"},{"key":"633_CR13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, et al. Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 2009;8:791\u2013801.","journal-title":"Lancet Neurol"},{"key":"633_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","volume":"10","author":"SJ Tabrizi","year":"2011","unstructured":"Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, et al. Biological and clinical changes in premanifest and early stage Huntington\u2019s disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol. 2011;10:31\u201342.","journal-title":"Lancet Neurol"},{"key":"633_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","volume":"11","author":"SJ Tabrizi","year":"2012","unstructured":"Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, et al. Potential endpoints for clinical trials in premanifest and early Huntington\u2019s disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol. 2012;11:42\u201353.","journal-title":"Lancet Neurol"},{"key":"633_CR16","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","volume":"12","author":"SJ Tabrizi","year":"2013","unstructured":"Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, et al. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol. 2013;12:637\u201349.","journal-title":"Lancet Neurol"},{"key":"633_CR17","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","volume":"79","author":"JS Paulsen","year":"2008","unstructured":"Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, et al. Detection of Huntington\u2019s disease decades before diagnosis: the Predict-HD study. J Neurol, Neurosurg, Psychiatry. 2008;79:874\u201380.","journal-title":"J Neurol, Neurosurg, Psychiatry"},{"key":"633_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fnagi.2013.00012","volume":"5","author":"KM Biglan","year":"2013","unstructured":"Biglan KM, Zhang Y, Long JD, Geschwind M, Kang GA, Killoran A, et al. Refining the diagnosis of Huntington disease: the PREDICT-HD study. Front Aging Neurosci. 2013;5:12.","journal-title":"Front Aging Neurosci"},{"key":"633_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fnagi.2014.00078","volume":"6","author":"JS Paulsen","year":"2014","unstructured":"Paulsen JS, Long JD, Johnson HJ, Aylward EH, Ross CA, Williams JK, et al. Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: a decade of the PREDICT-HD Study. Front Aging Neurosci. 2014;6:78.","journal-title":"Front Aging Neurosci"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41431-020-0633-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-020-0633-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-020-0633-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T01:15:21Z","timestamp":1696122921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-020-0633-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["633"],"URL":"https:\/\/doi.org\/10.1038\/s41431-020-0633-9","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"type":"print","value":"1018-4813"},{"type":"electronic","value":"1476-5438"}],"subject":[],"published":{"date-parts":[[2020,5,13]]},"assertion":[{"value":"10 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Raymund Roos is an adviser of UniQure at the time this study was conducted. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}